{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:20:53Z","timestamp":1790403653160,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1053\/j.seminhematol.2010.11.004","type":"journal-article","created":{"date-parts":[[2011,1,12]],"date-time":"2011-01-12T05:43:28Z","timestamp":1294811008000},"page":"13-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Myelomagenesis: Capturing Early Microenvironment Changes"],"prefix":"10.1053","volume":"48","author":[{"given":"Neha","family":"Korde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Maric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2010.11.004_bib1","author":"Altekruse"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib2","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib3","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group molecular classification of multiple myeloma: spotlight review","volume":"23","author":"Fonseca","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib5","first-page":"200","article-title":"Plasma cell neoplasms","author":"McKenna","year":"2008"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathiesmultiple myelomarelated disorders: a report of the International Myeloma Working Group","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib9","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jcp.43.6.469","article-title":"Bone marrow biopsy in monoclonal gammopathies: correlations between pathological findings and clinical data","volume":"43","author":"Riccardi","year":"1990","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib11","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","article-title":"New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells","volume":"110","author":"Perez-Persona","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1309\/74R4TB90BUWH27JX","article-title":"Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma","volume":"121","author":"Lin","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/10428190701760532","article-title":"Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma","volume":"49","author":"Kraj","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib14","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood.V97.5.1155","article-title":"Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression","volume":"97","author":"Silvestris","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib15","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2010-03-274571","article-title":"In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2","volume":"116","author":"Maes","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib16","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2010-04-282848","article-title":"Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study","volume":"116","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib17","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1182\/blood.V87.11.4762.bloodjournal87114762","article-title":"Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies","volume":"87","author":"Bataille","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2004.05092.x","article-title":"Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)","volume":"126","author":"Politou","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1172\/JCI115305","article-title":"Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma","volume":"88","author":"Bataille","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0609.2008.01065.x","article-title":"Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma","volume":"80","author":"Kaiser","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V73.2.517.517","article-title":"Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6","volume":"73","author":"Klein","year":"1989","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2407-10-198","article-title":"Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays","volume":"10","author":"Mahtouk","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib23","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/eji.1830230408","article-title":"Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy","volume":"23","author":"Gaillard","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib24","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1172\/JCI114392","article-title":"Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias","volume":"84","author":"Bataille","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib25","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1182\/blood.V81.12.3357.3357","article-title":"Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells","volume":"81","author":"Hata","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02983377","article-title":"Survival and proliferation factors of normal and malignant plasma cells","volume":"78","author":"Klein","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib27","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1038\/sj.onc.1206423","article-title":"A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells","volume":"22","author":"Jourdan","year":"2003","journal-title":"Oncogene"},{"issue":"8","key":"10.1053\/j.seminhematol.2010.11.004_bib28","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood-2003-06-1984","article-title":"BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone","volume":"103","author":"Moreaux","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib29","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood-2007-05-075176","article-title":"Lymphoma dissemination: the other face of lymphocyte homing","volume":"110","author":"Pals","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1084\/jem.194.1.45","article-title":"A coordinated change in chemokine responsiveness guides plasma cell movements","volume":"194","author":"Hargreaves","year":"2001","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1634\/stemcells.22-1-65","article-title":"Mobilization of myeloma cells involves SDF-1\/CXCR4 signaling and downregulation of VLA-4","volume":"22","author":"Gazitt","year":"2004","journal-title":"Stem Cells"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib32","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/0008-5472.CAN-04-1687","article-title":"Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients","volume":"65","author":"Zannettino","year":"2005","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib33","first-page":"5850","article-title":"Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3'-kinase\/AKT signaling","volume":"63","author":"Tai","year":"2003","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib34","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood-2004-01-0236","article-title":"Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis","volume":"104","author":"Mori","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib35","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064.409k07_3064_3073","article-title":"Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma","volume":"93","author":"Vacca","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1369\/jhc.2008.952200","article-title":"Altered expression of fibronectin and collagens I and IV in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"57","author":"Tancred","year":"2009","journal-title":"J Histochem Cytochem"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib37","first-page":"3647","article-title":"Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization","volume":"55","author":"Pellat-Deceunynck","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4149\/neo_2010_02_102","article-title":"The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma","volume":"57","author":"Scudla","year":"2010","journal-title":"Neoplasma"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib39","doi-asserted-by":"crossref","first-page":"32628","DOI":"10.1074\/jbc.M806266200","article-title":"Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma","volume":"283","author":"Purushothaman","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib40","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/modpathol.3880435","article-title":"Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions","volume":"14","author":"Bayer-Garner","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib41","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.prp.2010.07.006","article-title":"Biological impact of vascular endothelial growth factor on vessel density and survival in multiple myeloma and plasmacytoma","volume":"206","author":"Swelam","year":"2010","journal-title":"Pathol Res Pract"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0093-7754(01)90025-9","article-title":"Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis","volume":"28","author":"Munshi","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/BF02982812","article-title":"Absence of clinical prognostic value of vascular endothelial growth factor and microvessel density in multiple myeloma","volume":"76","author":"Choi","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib44","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib45","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1158\/1078-0432.CCR-06-0323","article-title":"Tumor angiogenesis is associated with plasma levels of stromal-derived factor-1alpha in patients with multiple myeloma","volume":"12","author":"Martin","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib46","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood.V95.8.2630","article-title":"Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma","volume":"95","author":"Dankbar","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib47","first-page":"176","article-title":"A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma","volume":"88","author":"Vacca","year":"2003","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib48","first-page":"1033","article-title":"Differential expression of vascular endothelial growth factors and their receptors in multiple myeloma","volume":"91","author":"Kimlinger","year":"2006","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib49","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood-2003-08-2946","article-title":"Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity","volume":"103","author":"Asosingh","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib50","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1158\/1078-0432.CCR-08-2310","article-title":"Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation","volume":"15","author":"Hillengass","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.leu.2403647","article-title":"Clonal plasma cells from monoclonal gammopathy of undetermined significance, multiple myeloma and plasma cell leukemia show different expression profiles of molecules involved in the interaction with the immunological bone marrow microenvironment","volume":"19","author":"Perez-Andres","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib53","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.humimm.2009.07.004","article-title":"Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells","volume":"70","author":"Bernal","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib54","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1182\/blood-2002-04-1284","article-title":"Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction","volume":"100","author":"Spaggiari","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/intimm\/12.2.195","article-title":"Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8(+) Fas (CD95)(+) T lymphocytes","volume":"12","author":"Puppo","year":"2000","journal-title":"Int Immunol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib56","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2009-06-228676","article-title":"Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma","volume":"115","author":"Racanelli","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib57","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/cncr.21746","article-title":"Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic\/Th1 T cells demonstrating a squed TCR-Vbeta repertoire","volume":"106","author":"Perez-Andres","year":"2006","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib58","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1002\/eji.1830270919","article-title":"T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden","volume":"27","author":"Halapi","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib59","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1084\/jem.20062387","article-title":"Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy","volume":"204","author":"Spisek","year":"2007","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib60","doi-asserted-by":"crossref","first-page":"13009","DOI":"10.1073\/pnas.202491499","article-title":"T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells","volume":"99","author":"Dhodapkar","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib61","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.20031030","article-title":"Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy","volume":"198","author":"Dhodapkar","year":"2003","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib62","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1084\/jem.20021650","article-title":"A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma","volume":"197","author":"Dhodapkar","year":"2003","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib63","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00262-009-0807-3","article-title":"Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked","volume":"59","author":"von Lilienfeld-Toal","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1053\/j.seminhematol.2010.11.004_bib64","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0711293105","article-title":"MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma","volume":"105","author":"Jinushi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196310001071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196310001071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:21:36Z","timestamp":1758522096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196310001071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0037196310001071"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2010.11.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myelomagenesis: Capturing Early Microenvironment Changes","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2010.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}